Author Guidelines
About These Guidelines
The Clinical Journal of Pharmacology and Therapeutics provides these guidelines to help authors prepare manuscripts for editorial assessment and publication. Authors should ensure that submissions are scientifically sound, clearly written, ethically conducted, and complete.
Manuscripts should follow the requirements appropriate to their article type and, where applicable, relevant reporting standards.
Submission email: submission@clinicalpharmtherapeutics.com
Scope and Article Types
The journal considers research and scholarly contributions in pharmacology, clinical pharmacology, therapeutics, medicines, drug development, pharmacotherapy, medication safety, pharmacokinetics, pharmacodynamics, and related clinical and biomedical fields.
Article types may include:
Original Research
Review Articles
Systematic Reviews and Meta-Analyses
Case Reports
Clinical Images
Short Communications
Editorials
Commentaries
Special Issue Articles
The structure and length may vary according to the article type.
Submission Requirements
Submission confirms that:
The manuscript is original and is not under consideration elsewhere.
All authors have approved the submitted version.
The corresponding author is authorized to act on behalf of the authors.
Appropriate ethical approval and informed consent have been obtained where required.
Funding and competing interests have been disclosed.
Permission has been obtained for copyrighted or third-party material.
Related publications, preprints, or overlapping submissions have been disclosed.
Manuscript Preparation
Manuscripts should be written in English and submitted as an editable Microsoft Word document.
Where applicable, the manuscript should include:
Title
Author names and affiliations
Abstract
Keywords
Main text
Declarations
References
Tables
Figure legends
Figures and supplementary material
For original research, the usual structure is Introduction, Methods, Results, and Discussion (IMRaD). Other article types may use a different structure.
Basic Formatting
Page size: 8.5 × 11 inches
Margins: 1 inch
Font: Times New Roman, 10-point
Line spacing: Single
Alignment: Justified
Authors should maintain consistent terminology, abbreviations, units, spelling, and formatting throughout the manuscript.
Abstract and Keywords
The abstract should accurately summarize the manuscript and generally should not exceed 250 words, unless otherwise specified for the article type.
Depending on the article category, abstracts may be structured or unstructured.
Authors should provide relevant keywords after the abstract. Keywords should be specific, appropriate to the subject, and separated by semicolons.
Main Manuscript
The manuscript should present the work clearly and logically.
Introduction
Explain the background, relevant evidence, knowledge gap, and purpose of the work.
Methods
Provide sufficient information about the study design, participants or materials, procedures, outcomes, statistical methods, ethical approval, and other relevant procedures.
Results
Present findings clearly and in a logical order. Avoid unnecessary duplication between the text, tables, and figures.
Discussion
Interpret the findings in relation to existing evidence and address important strengths, limitations, implications, and alternative explanations.
Conclusion
Provide a concise conclusion supported by the findings. Avoid claims that extend beyond the evidence.
Tables, Figures, and References
Tables and figures should be numbered consecutively and cited in the text.
Tables should be editable and include clear titles, headings, and explanatory notes where necessary.
Figures should be clear and suitable for publication. TIFF or JPEG formats are recommended, with approximately 300 dpi for publication-quality images.
The journal uses a Vancouver-style numbered reference system. References should appear in the order of first citation and should be checked carefully for accuracy and completeness.
Research Ethics and Patient Consent
Research involving human participants, animals, patient data, or biological materials must comply with applicable ethical requirements.
Where applicable, authors should provide ethics committee or institutional review board information, approval numbers, informed-consent statements, and clinical trial registration details.
Identifiable patient information should not be published without appropriate consent. Authors should retain consent documentation and provide it to the journal when requested.
Authorship, Funding, and Competing Interests
All listed authors should have made meaningful contributions to the work, approved the final manuscript, and accept responsibility for its content.
Funding sources and relevant financial or professional relationships must be disclosed.
Where there are no competing interests or specific funding, authors should provide an appropriate declaration.
Data Availability and Reporting Standards
Authors should provide a data availability statement where applicable.
Authors are encouraged to follow recognized reporting guidelines appropriate to their study design, including relevant standards for clinical trials, systematic reviews, observational studies, diagnostic research, and case reports.
Artificial Intelligence
Use of AI-assisted technologies during manuscript preparation should be disclosed at submission, including the tool used and its role.
AI tools must not be listed as authors. Authors remain fully responsible for the accuracy, originality, references, confidentiality, and integrity of the submitted manuscript.
Editorial Review and Revision
Manuscripts may undergo an initial editorial assessment before external peer review. Suitability, scientific quality, ethical compliance, completeness, and relevance to the journal may be considered.
When revisions are requested, authors should provide a revised manuscript together with a clear response to reviewer comments.
Proofs
After acceptance and production, the corresponding author will receive an electronic proof. Authors should review the proof carefully and return essential corrections within 2 working days, unless otherwise advised.
Article Processing Charges (APC)
There is no submission or peer-review fee.
For accepted manuscripts, an Article Processing Charge (APC) of USD 2400–3400 may apply. The APC supports editorial administration, peer-review coordination, production, online publication, and digital preservation.
APC considerations do not influence editorial or peer-review decisions.
Waivers and Withdrawal
Authors experiencing financial difficulties may contact the Editorial Office to enquire about available APC reductions or waivers. Requests are considered separately from editorial decisions.
Authors may request withdrawal before peer review begins without a withdrawal charge. Withdrawal after peer review has commenced may be subject to applicable administrative charges.
Submission Checklist
Before submission, authors should confirm that:
The manuscript follows the appropriate article structure.
All authors have approved the manuscript.
Ethical approval and consent requirements have been addressed.
Funding and competing interests have been disclosed.
References, tables, and figures are complete and accurate.
Required permissions have been obtained.
AI-assisted technologies have been disclosed where applicable.
The manuscript is not under consideration elsewhere.